BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 377651)

  • 1. Mitigation of hyperacute rejection by antilymphocyte globulin (ALG).
    Hammer C; Krebs G; Chaussy C; Pfeifer K; Schmidt K; Land W; Brendel W
    Transplant Proc; 1979 Mar; 11(1):31-5. PubMed ID: 377651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active enhancement of dog kidney allografts using ALG and donor platelets.
    Rowiński W; Ryffa T; Stepkowski S; Woźniewicz B; Ruka M; Wasowska B; Hay M; Olszewski W
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1013-9. PubMed ID: 373670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival of heart transplants. Graft and/or donor pretreatment with antilymphoblast globulin, cyclophosphamide, or methylprednisolone.
    Toledo-Pereyra LH; Condie RM
    J Thorac Cardiovasc Surg; 1978 Apr; 75(4):536-41. PubMed ID: 347179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
    Taylor HE; Ackman CF; Horowitz I
    Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
    McAlack RF; Stern S; Beizer R; Sklar L; Bannett A
    Transplant Proc; 1979 Jun; 11(2):1431-2. PubMed ID: 382532
    [No Abstract]   [Full Text] [Related]  

  • 6. Rejection prophylaxis with antilymphocyte globulin for cardiac transplantation in Oriental recipients.
    Wei J; Chang CY; Lee FY; Song YB; Jiau SF
    Transplant Proc; 1992 Aug; 24(4):1493-7. PubMed ID: 1496632
    [No Abstract]   [Full Text] [Related]  

  • 7. Antilymphoblast globulin (ALG) as initial prophylaxis against rejection following liver transplantation.
    Greig PD; Levy G; Superina RA; Strasberg SM; Taylor BR; Blendis LM; Cameron R; Phillips MJ; Langer B
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2244-6. PubMed ID: 2652728
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged survival of canine liver allografts perfused with antilymphocyte globulin (ALG).
    Toledo-Pereyra LH; Condie RM; Callender CO; Sharp H; Buselmeier TJ; Simmons RL; Najarian JS
    Trans Am Soc Artif Intern Organs; 1976; 22():211-5. PubMed ID: 781981
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of antilymphocyte globulin in renal allograft rejection. A controlled study.
    Birkeland SA
    Postgrad Med J; 1976; 52(5 Suppl):82-8. PubMed ID: 792853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
    Boratyńska M; Szepietowski T; Szewczyk Z; Szydłowski Z
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):163-8. PubMed ID: 1299176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized production in goats of antilymphocyte globulin and its clinical use.
    Sheil AG; Mears DC; Kelley GE
    Prog Biochem Pharmacol; 1974; 9():99-106. PubMed ID: 4216036
    [No Abstract]   [Full Text] [Related]  

  • 12. Early, low dose rabbit ALG therapy in cadaver kidney transplantation.
    Mannick JA; Nabseth DC; Olsson CA; Davis RC
    Transplant Proc; 1972 Dec; 4(4):497-9. PubMed ID: 4566794
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppression and clinical organ transplantation.
    Calne RY
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):49-51. PubMed ID: 4612904
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical aspects of allograft rejection.
    Williams GM
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):71-7. PubMed ID: 4612907
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental kidney transplantation.
    Skośkiewicz M; Rowiński W
    Pol Med J; 1971; 10(2):455-8. PubMed ID: 4934235
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of antilymphocytic immunoglobulin from donkeys in kidney allotransplantation to dogs].
    Aripov UA; Arustamov DL; Karimov ShI; Popova VS; Al'bekova SN
    Eksp Khir Anesteziol; 1971; 16(2):13-7. PubMed ID: 4946088
    [No Abstract]   [Full Text] [Related]  

  • 17. New approaches to immunosuppression in renal transplantation.
    Stuart FP
    Urol Clin North Am; 1976 Oct; 3(3):575-96. PubMed ID: 790732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of pancreatic islet cell allograft survival by graft pretreatment with antilymphoblast globulin (ALG).
    Toledo-Pereyra LH; Gordon DA; MacKenzie GH
    Am Surg; 1982 Jun; 48(6):282-6. PubMed ID: 6805380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of the current status of the clinical uses of antilymphocyte serum.
    Monaco AP; Codish SD
    Surg Gynecol Obstet; 1976 Mar; 142(3):417-26. PubMed ID: 766248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Change in the activity of arginase in the blood following renal allotransplantation and use of antilymphocyte globulin as an immunodepressant].
    Petrun' MM; Migal' LA; Drannik GN
    Fiziol Zh; 1976; 22(5):671-4. PubMed ID: 789122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.